The genetic and clinical features of African Americans
(AA) with multiple sclerosis (MS) reported in the article by Cree et al [1] may also apply to Blacks with African genetics in
the rest of the American continent. Africans, particularly West Sub-
Saharan Africans, were initially brought in large numbers during the late
seventeenth century to this continent and readily intermixed with European
Caucasians specially in some Latin American areas including: Caribbean islands,
Central America, Venezuela, Colombia, Ecuador, Peru and Brazil.
In Brazil, it has been reported that almost half of patients with MS
(Rio de Janeiro) are "Afro-Brazilian" (Mulattos) with a susceptibility
locus in DQB1*0602.[2] This may also suggest a European ancestry
component.
Although an in-depth genetic analysis has not been completed,
Colombian [3] and Brazilian [4] studies report high
frequency of visual and spinal abnormalities at onset and during the
course of MS and a higher frequency than expected in these groups (comparison to published
data) for Neuromyelitis Optica. [5]
The Latin American Committee for Treatment and Research in MS
(LACTRIMS) has identified similar clinical trends for the main racial core
of Latin America: Mestizos. This group represents a complex admixture of
Caucasian and American native inhabitants in whom ancestral Mongoloid
genetics have been described, and that together with AA, constitute
relatively recent genetic events developed over the last five centuries.
According to observations from LACTRIMS studies Mestizos appear to share
genetics similar to Europeans at higher risk for MS. Studies on Genotypic
responses to MS therapies among AA and Mestizos in Latin America should be
encouraged considering the apparent increase in frequency of the disease
in this region.
References
1.Cree BAC, Khan O, Bourdette D, et al. Clinical characteristics of
African Americans vs Caucasian Americans with multiple sclerosis.
Neurology 2004;63: 2039-2045.
2.Caballero A, Alves-Leon S, Papais-Alvarenga R, et al. DQB1*0602
confers genetic susceptibility to multiple sclerosis in Afro-Brazilians.
Tissue Antigens 1999;54:524-546.
3.Sanchez JL, Palacio LG, Uribe CS, et al. Clinical features of
multiple sclerosis in a genetically homogenous tropical population. Mult
Scler 2001;7:227-229.
4.Lana-Peixoto MA, Lana-Peixoto MI.Is multiple sclerosis in Brazil
and Asia alike?.Arq Neuropsiquiatr 1992;50:419-425.
5.Patrucco LB,Cristiano E,Videla GC,et al.Devic's Neuromyelitis
Optica (NMO)and Multiple Sclerosis (MS); Clinical and Epidemiological
findings in a MS Center in Argentina. Mult Scler 2002;Vol 8:(Suppl),P51.
The authors had the opportunity to respond to this Correspondence but declined.